← All trials
NCT04452136
N/AExpanded Access
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- —
- Primary completion
- —
- Completion date
- —
- First posted
- Jun 30, 2020
- Last posted
- Jun 30, 2020
- Enrollment
- —
- Arms / groups
- — / —
- Source
- AACT · ingestion pipeline
Sponsors
- Oregon Health and Science UniversityLead sponsor
- Oregon Health and Science UniversityCollaborator
- OHSU Knight Cancer InstituteSponsor investigator
- OHSU Knight Cancer InstituteOverall official - principal investigator
- OHSU Knight Cancer InstituteCollaborator
- Oregon Health and Science UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.